RE: Yesterday20 Oct 2021 11:01
What matters most here are human data results, partnerships with bigger pharma,licensing out products , revenues ,and fcf..
Opening another shop or recruiting more staff and spending are not what the market is waiting for in a company that has been doing R&D for 25 years with no revenues or human data results.
The market reaction and trading volumes yesterday to the RNS was obvious to all holders to see.
Still holding strong and hopefully incoming news would be positive ..next week.
40p by end of November is still my expectations…
Back to the few holding their hallow vessel with their unrivalled views!
GL